2026-2032 Global In-Vitro Diagnostics Industry Research & Trends Analysis Report- YH Research

日本语 | 中文

Home > Reports >Medical Care > 2026-2032 Global In-Vitro Diagnostics Industry Research & Trends Analysis Report

2026-2032 Global In-Vitro Diagnostics Industry Research & Trends Analysis Report

Publication Date: 2026-07-12
Report Id: 2811093
Industry: Medical Care
Report Page: 138
Chart: 144

PDF Download

Publication Date: 2026-07-12
Report Id: 2811093
Industry: Medical Care
Report Page: 138
Chart: 144

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Product Overview and Scope of In-Vitro Diagnostics
1.2 Global In-Vitro Diagnostics Market Size and Forecast
1.3 China In-Vitro Diagnostics Market Size and Forecast
1.4 China Percentage in Global Market
1.4.1 By Revenue, China In-Vitro Diagnostics Share in Global Market, 2021-2032
1.4.2 In-Vitro Diagnostics Market Size: China VS Global, 2021-2032
1.5 In-Vitro Diagnostics Market Dynamics
1.5.1 In-Vitro Diagnostics Market Drivers
1.5.2 In-Vitro Diagnostics Market Restraints
1.5.3 In-Vitro Diagnostics Industry Trends
1.5.4 In-Vitro Diagnostics Industry Policy

2 Competitive Landscape by Company
2.1 Global In-Vitro Diagnostics Revenue by Company, 2021-2026
2.2 Global In-Vitro Diagnostics Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global In-Vitro Diagnostics Concentration Ratio
2.4 Global In-Vitro Diagnostics Mergers & Acquisitions, Expansion Plans
2.5 Global In-Vitro Diagnostics Manufacturers Product Type
2.6 Global Geographic Distribution of In-Vitro Diagnostics Companies

3 China Competitive Situation by Company
3.1 China In-Vitro Diagnostics Revenue by Company, 2021-2026
3.2 China In-Vitro Diagnostics In-Vitro Diagnostics Participants, Market Position (Tier 1, Tier 2, and Tier 3)
3.3 China In-Vitro Diagnostics Market, Revenue Percentage of Local Players VS Foreign Players (2021-2032)

4 Industry Chain Analysis
4.1 In-Vitro Diagnostics Industry Chain
4.2 In-Vitro Diagnostics Upstream Analysis
4.3 In-Vitro Diagnostics Midstream Analysis
4.4 In-Vitro Diagnostics Downstream Analysis

5 Sights by Type
5.1 In-Vitro Diagnostics Classification by Type
5.1.1 Molecular Diagnostics
5.1.2 Immuno Diagnostics
5.1.3 Chemistry Diagnostics
5.1.4 POCT
5.1.5 Other
5.2 by Type, Global In-Vitro Diagnostics Market Size & CAGR, 2021 VS 2025 VS 2032
5.3 by Type, Global In-Vitro Diagnostics Market Size, 2021-2032

6 Sights by Sample
6.1 In-Vitro Diagnostics Classification by Sample
6.1.1 Blood
6.1.2 Urine
6.1.3 Saliva
6.1.4 Other
6.2 by Sample, Global In-Vitro Diagnostics Market Size & CAGR, 2021 VS 2025 VS 2032
6.3 by Sample, Global In-Vitro Diagnostics Market Size, 2021-2032

7 Sights by Product Form
7.1 In-Vitro Diagnostics Classification by Product Form
7.1.1 Equipment
7.1.2 Consumables
7.2 by Product Form, Global In-Vitro Diagnostics Market Size & CAGR, 2021 VS 2025 VS 2032
7.3 by Product Form, Global In-Vitro Diagnostics Market Size, 2021-2032

8 Sights by Application
8.1 In-Vitro Diagnostics Segment by Application
8.1.1 Hospital
8.1.2 Laboratory
8.1.3 Household
8.1.4 Others
8.2 by Application, Global In-Vitro Diagnostics Market Size & CAGR, 2021 VS 2025 VS 2032
8.3 by Application, Global In-Vitro Diagnostics Market Size, 2021-2032

9 Sights by Region
9.1 By Region, Global In-Vitro Diagnostics Market Size, 2021 VS 2025 VS 2032
9.2 By Region, Global In-Vitro Diagnostics Market Size, 2021-2032
9.3 North America
9.3.1 North America In-Vitro Diagnostics Market Size & Forecasts, 2021-2032
9.3.2 By Country, North America In-Vitro Diagnostics Market Size Market Share
9.4 Europe
9.4.1 Europe In-Vitro Diagnostics Market Size & Forecasts, 2021-2032
9.4.2 By Country, Europe In-Vitro Diagnostics Market Size Market Share
9.5 Asia Pacific
9.5.1 Asia Pacific In-Vitro Diagnostics Market Size & Forecasts, 2021-2032
9.5.2 By Country/Region, Asia Pacific In-Vitro Diagnostics Market Size Market Share
9.6 South America
9.6.1 South America In-Vitro Diagnostics Market Size & Forecasts, 2021-2032
9.6.2 By Country, South America In-Vitro Diagnostics Market Size Market Share
9.7 Middle East & Africa

10 Sights by Country Level
10.1 By Country, Global In-Vitro Diagnostics Market Size & CAGR，2021 VS 2025 VS 2032
10.2 By Country, Global In-Vitro Diagnostics Market Size, 2021-2032
10.3 United States
10.3.1 United States In-Vitro Diagnostics Market Size, 2021-2032
10.3.2 By Company, United States In-Vitro Diagnostics Revenue Market Share, 2025
10.3.3 by Type, United States In-Vitro Diagnostics Revenue Market Share, 2025 VS 2032
10.3.4 by Application, United States In-Vitro Diagnostics Revenue Market Share, 2025 VS 2032
10.4 Europe
10.4.1 Europe In-Vitro Diagnostics Market Size, 2021-2032
10.4.2 By Company, Europe In-Vitro Diagnostics Revenue Market Share, 2025
10.4.3 by Type, Europe In-Vitro Diagnostics Revenue Market Share, 2025 VS 2032
10.4.4 by Application, Europe In-Vitro Diagnostics Revenue Market Share, 2025 VS 2032
10.5 China
10.5.1 China In-Vitro Diagnostics Market Size, 2021-2032
10.5.2 By Company, China In-Vitro Diagnostics Revenue Market Share, 2025
10.5.3 by Type, China In-Vitro Diagnostics Revenue Market Share, 2025 VS 2032
10.5.4 by Application, China In-Vitro Diagnostics Revenue Market Share, 2025 VS 2032
10.6 Japan
10.6.1 Japan In-Vitro Diagnostics Market Size, 2021-2032
10.6.2 By Company, Japan In-Vitro Diagnostics Revenue Market Share, 2025
10.6.3 by Type, Japan In-Vitro Diagnostics Revenue Market Share, 2025 VS 2032
10.6.4 by Application, Japan In-Vitro Diagnostics Revenue Market Share, 2025 VS 2032
10.7 South Korea
10.7.1 South Korea In-Vitro Diagnostics Market Size, 2021-2032
10.7.2 By Company, South Korea In-Vitro Diagnostics Revenue Market Share, 2025
10.7.3 by Type, South Korea In-Vitro Diagnostics Revenue Market Share, 2025 VS 2032
10.7.4 by Application, South Korea In-Vitro Diagnostics Revenue Market Share, 2025 VS 2032
10.8 Southeast Asia
10.8.1 Southeast Asia In-Vitro Diagnostics Market Size, 2021-2032
10.8.2 By Company, Southeast Asia In-Vitro Diagnostics Revenue Market Share, 2025
10.8.3 by Type, Southeast Asia In-Vitro Diagnostics Revenue Market Share, 2025 VS 2032
10.8.4 by Application, Southeast Asia In-Vitro Diagnostics Revenue Market Share, 2025 VS 2032
10.9 India
10.9.1 India In-Vitro Diagnostics Market Size, 2021-2032
10.9.2 By Company, India In-Vitro Diagnostics Revenue Market Share, 2025
10.9.3 by Type, India In-Vitro Diagnostics Revenue Market Share, 2025 VS 2032
10.9.4 by Application, India In-Vitro Diagnostics Revenue Market Share, 2025 VS 2032
10.10 Middle East & Africa
10.10.1 Middle East & Africa In-Vitro Diagnostics Market Size, 2021-2032
10.10.2 By Company, Middle East & Africa In-Vitro Diagnostics Revenue Market Share, 2025
10.10.3 by Type, Middle East & Africa In-Vitro Diagnostics Revenue Market Share, 2025 VS 2032
10.10.4 by Application, Middle East & Africa In-Vitro Diagnostics Revenue Market Share, 2025 VS 2032

11 Company Profile
11.1 Roche
11.1.1 Roche Company Information, Head Office, Market Area, and Industry Position
11.1.2 Roche Company Profile and Main Business
11.1.3 Roche In-Vitro Diagnostics Models, Specifications, and Application
11.1.4 Roche In-Vitro Diagnostics Revenue and Gross Margin, 2021-2026
11.1.5 Roche Recent Developments
11.2 Abbott
11.2.1 Abbott Company Information, Head Office, Market Area, and Industry Position
11.2.2 Abbott Company Profile and Main Business
11.2.3 Abbott In-Vitro Diagnostics Models, Specifications, and Application
11.2.4 Abbott In-Vitro Diagnostics Revenue and Gross Margin, 2021-2026
11.2.5 Abbott Recent Developments
11.3 Danaher
11.3.1 Danaher Company Information, Head Office, Market Area, and Industry Position
11.3.2 Danaher Company Profile and Main Business
11.3.3 Danaher In-Vitro Diagnostics Models, Specifications, and Application
11.3.4 Danaher In-Vitro Diagnostics Revenue and Gross Margin, 2021-2026
11.3.5 Danaher Recent Developments
11.4 Siemens Healthineers
11.4.1 Siemens Healthineers Company Information, Head Office, Market Area, and Industry Position
11.4.2 Siemens Healthineers Company Profile and Main Business
11.4.3 Siemens Healthineers In-Vitro Diagnostics Models, Specifications, and Application
11.4.4 Siemens Healthineers In-Vitro Diagnostics Revenue and Gross Margin, 2021-2026
11.4.5 Siemens Healthineers Recent Developments
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Information, Head Office, Market Area, and Industry Position
11.5.2 Thermo Fisher Scientific Company Profile and Main Business
11.5.3 Thermo Fisher Scientific In-Vitro Diagnostics Models, Specifications, and Application
11.5.4 Thermo Fisher Scientific In-Vitro Diagnostics Revenue and Gross Margin, 2021-2026
11.5.5 Thermo Fisher Scientific Recent Developments
11.6 Sysmex
11.6.1 Sysmex Company Information, Head Office, Market Area, and Industry Position
11.6.2 Sysmex Company Profile and Main Business
11.6.3 Sysmex In-Vitro Diagnostics Models, Specifications, and Application
11.6.4 Sysmex In-Vitro Diagnostics Revenue and Gross Margin, 2021-2026
11.6.5 Sysmex Recent Developments
11.7 BioMerieux
11.7.1 BioMerieux Company Information, Head Office, Market Area, and Industry Position
11.7.2 BioMerieux Company Profile and Main Business
11.7.3 BioMerieux In-Vitro Diagnostics Models, Specifications, and Application
11.7.4 BioMerieux In-Vitro Diagnostics Revenue and Gross Margin, 2021-2026
11.7.5 BioMerieux Recent Developments
11.8 QuidelOrtho
11.8.1 QuidelOrtho Company Information, Head Office, Market Area, and Industry Position
11.8.2 QuidelOrtho Company Profile and Main Business
11.8.3 QuidelOrtho In-Vitro Diagnostics Models, Specifications, and Application
11.8.4 QuidelOrtho In-Vitro Diagnostics Revenue and Gross Margin, 2021-2026
11.8.5 QuidelOrtho Recent Developments
11.9 Becton Dickinson
11.9.1 Becton Dickinson Company Information, Head Office, Market Area, and Industry Position
11.9.2 Becton Dickinson Company Profile and Main Business
11.9.3 Becton Dickinson In-Vitro Diagnostics Models, Specifications, and Application
11.9.4 Becton Dickinson In-Vitro Diagnostics Revenue and Gross Margin, 2021-2026
11.9.5 Becton Dickinson Recent Developments
11.10 Bio-Rad Laboratories
11.10.1 Bio-Rad Laboratories Company Information, Head Office, Market Area, and Industry Position
11.10.2 Bio-Rad Laboratories Company Profile and Main Business
11.10.3 Bio-Rad Laboratories In-Vitro Diagnostics Models, Specifications, and Application
11.10.4 Bio-Rad Laboratories In-Vitro Diagnostics Revenue and Gross Margin, 2021-2026
11.10.5 Bio-Rad Laboratories Recent Developments
11.11 Hologic
11.11.1 Hologic Company Information, Head Office, Market Area, and Industry Position
11.11.2 Hologic Company Profile and Main Business
11.11.3 Hologic In-Vitro Diagnostics Models, Specifications, and Application
11.11.4 Hologic In-Vitro Diagnostics Revenue and Gross Margin, 2021-2026
11.11.5 Hologic Recent Developments
11.12 LifeScan
11.12.1 LifeScan Company Information, Head Office, Market Area, and Industry Position
11.12.2 LifeScan Company Profile and Main Business
11.12.3 LifeScan In-Vitro Diagnostics Models, Specifications, and Application
11.12.4 LifeScan In-Vitro Diagnostics Revenue and Gross Margin, 2021-2026
11.12.5 LifeScan Recent Developments
11.13 Qiagen
11.13.1 Qiagen Company Information, Head Office, Market Area, and Industry Position
11.13.2 Qiagen Company Profile and Main Business
11.13.3 Qiagen In-Vitro Diagnostics Models, Specifications, and Application
11.13.4 Qiagen In-Vitro Diagnostics Revenue and Gross Margin, 2021-2026
11.13.5 Qiagen Recent Developments
11.14 Wuhan Easy Diagnosis
11.14.1 Wuhan Easy Diagnosis Company Information, Head Office, Market Area, and Industry Position
11.14.2 Wuhan Easy Diagnosis Company Profile and Main Business
11.14.3 Wuhan Easy Diagnosis In-Vitro Diagnostics Models, Specifications, and Application
11.14.4 Wuhan Easy Diagnosis In-Vitro Diagnostics Revenue and Gross Margin, 2021-2026
11.14.5 Wuhan Easy Diagnosis Recent Developments
11.15 Wondfo
11.15.1 Wondfo Company Information, Head Office, Market Area, and Industry Position
11.15.2 Wondfo Company Profile and Main Business
11.15.3 Wondfo In-Vitro Diagnostics Models, Specifications, and Application
11.15.4 Wondfo In-Vitro Diagnostics Revenue and Gross Margin, 2021-2026
11.15.5 Wondfo Recent Developments
11.16 KHB
11.16.1 KHB Company Information, Head Office, Market Area, and Industry Position
11.16.2 KHB Company Profile and Main Business
11.16.3 KHB In-Vitro Diagnostics Models, Specifications, and Application
11.16.4 KHB In-Vitro Diagnostics Revenue and Gross Margin, 2021-2026
11.16.5 KHB Recent Developments
11.17 Hotgen
11.17.1 Hotgen Company Information, Head Office, Market Area, and Industry Position
11.17.2 Hotgen Company Profile and Main Business
11.17.3 Hotgen In-Vitro Diagnostics Models, Specifications, and Application
11.17.4 Hotgen In-Vitro Diagnostics Revenue and Gross Margin, 2021-2026
11.17.5 Hotgen Recent Developments
11.18 Mindray
11.18.1 Mindray Company Information, Head Office, Market Area, and Industry Position
11.18.2 Mindray Company Profile and Main Business
11.18.3 Mindray In-Vitro Diagnostics Models, Specifications, and Application
11.18.4 Mindray In-Vitro Diagnostics Revenue and Gross Margin, 2021-2026
11.18.5 Mindray Recent Developments
11.19 Sinocare
11.19.1 Sinocare Company Information, Head Office, Market Area, and Industry Position
11.19.2 Sinocare Company Profile and Main Business
11.19.3 Sinocare In-Vitro Diagnostics Models, Specifications, and Application
11.19.4 Sinocare In-Vitro Diagnostics Revenue and Gross Margin, 2021-2026
11.19.5 Sinocare Recent Developments
11.20 Getein Biotech
11.20.1 Getein Biotech Company Information, Head Office, Market Area, and Industry Position
11.20.2 Getein Biotech Company Profile and Main Business
11.20.3 Getein Biotech In-Vitro Diagnostics Models, Specifications, and Application
11.20.4 Getein Biotech In-Vitro Diagnostics Revenue and Gross Margin, 2021-2026
11.20.5 Getein Biotech Recent Developments

12 Conclusion

13 Appendix
13.1 Research Methodology
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Market Estimation Model
13.4 Disclaimer

According to YH Research, the global market for In-Vitro Diagnostics should grow from US$ 92356 million in 2025 to US$ 120193 million by 2032, with a CAGR of 3.9% for the period of 2026-2032.

In-Vitro Diagnostics (IVD) comprise medical products and technologies used outside the human body to examine blood, urine, tissue, saliva and other human specimens through diagnostic reagents, analytical instruments, calibrators, controls and supporting software. They provide information for disease screening, diagnosis, treatment selection, therapeutic monitoring, prognosis and health management. Major fields include clinical chemistry, immunodiagnostics, molecular diagnostics, hematology, coagulation testing, microbiology, pathology and point-of-care testing. Applications extend from central and hospital laboratories to emergency departments, primary-care facilities and home settings. This scope includes instruments, reagents and related consumables, while excluding testing services provided by independent clinical laboratories.

In-Vitro Diagnostics

According to YH Research, the global market for In-Vitro Diagnostics should grow from US$ 92356 million in 2025 to US$ 120193 million by 2032, with a CAGR of 3.9% for the period of 2026-2032.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

Population aging, chronic-disease management, precision oncology and infectious-disease control are expanding the need for diagnostic testing, while clinical decisions increasingly depend on measurable biomarkers. As molecular testing, digital pathology and companion diagnostics become more deeply integrated into care pathways, IVD is evolving from a tool for confirming disease into a clinical-information platform supporting screening, classification, treatment selection and follow-up. The expansion of primary care and point-of-care testing is also moving diagnostics beyond large laboratories toward emergency departments, clinics and patients, creating new opportunities for portable and rapid-testing systems. 
The industry must manage pricing pressure, evolving regulation and rapid technological change. Because test results directly influence clinical decisions, manufacturers must continuously demonstrate analytical performance, clinical performance, lot consistency and specimen suitability, supported by quality systems covering production, distribution, laboratory use and post-market surveillance. Europe’s IVDR has strengthened requirements relating to classification, clinical evidence and lifecycle oversight, while the United States applies premarket and post-market controls according to IVD risk. Hospital cost containment, centralized procurement and competition among similar assays may further pressure margins in mature product categories. 
Laboratory purchasing is shifting from isolated assay performance toward total operational efficiency. Large hospitals increasingly value automated sample handling, integrated laboratory lines, result verification, information-system connectivity and cross-platform quality management, while primary-care facilities prioritize compact size, low maintenance and ease of use. The model of instrument placement followed by recurring reagent consumption remains fundamental, but open data interfaces, remote service and intelligent interpretation are emerging as additional competitive factors. Customers increasingly favor suppliers capable of covering central laboratories, specialty testing and point-of-care applications through a stable, integrated service platform.

This report aims to provide a comprehensive study of the global market for In-Vitro Diagnostics. Report Highlights:
(1) Global In-Vitro Diagnostics market size (value), history data from 2021-2025, and forecast data from 2026 to 2032.

(2) Global In-Vitro Diagnostics market competitive situation, revenue, and market share, from 2021 to 2025.

(3) China In-Vitro Diagnostics market competitive situation, revenue, and market share, from 2021 to 2025.

(4) Global In-Vitro Diagnostics segment by region (or country), key regions cover the United States, Europe, China, Japan, South Korea, Southeast Asia, and India, etc.

(5) Global In-Vitro Diagnostics segment by Type, and by Application, and regional segment by Type, and by Application.

(6) In-Vitro Diagnostics industry supply chain, upstream, midstream, and downstream analysis.

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by Type, covers
    Molecular Diagnostics
    Immuno Diagnostics
    Chemistry Diagnostics
    POCT
    Other

Market segment by Sample, covers
    Blood
    Urine
    Saliva
    Other

Market segment by Product Form, covers
    Equipment
    Consumables

Market segment by Application, can be divided into
    Hospital
    Laboratory
    Household
    Others

Market segment by players, this report covers
    Roche
    Abbott
    Danaher
    Siemens Healthineers
    Thermo Fisher Scientific
    Sysmex
    BioMerieux
    QuidelOrtho
    Becton Dickinson
    Bio-Rad Laboratories
    Hologic
    LifeScan
    Qiagen
    Wuhan Easy Diagnosis
    Wondfo
    KHB
    Hotgen
    Mindray
    Sinocare
    Getein Biotech